Serum antibody responses to Clostridium difficile toxin A: predictive and protective?
作者信息
Phillips C
机构信息
Department of Veterinary Pathology University of Edinburgh Easter, Bush Veterinary Centre, Roslin, Midlothian EH25 9RG, UK.
出版信息
Gut. 2001 Aug;49(2):167-8. doi: 10.1136/gut.49.2.167.
Abstract
摘要
相似文献
1
Serum antibody responses to Clostridium difficile toxin A: predictive and protective?
Gut. 2001 Aug;49(2):167-8. doi: 10.1136/gut.49.2.167.
2
Antibodies to Toxin B Are Protective Against Clostridium difficile Infection Recurrence.
Clin Infect Dis. 2016 Sep 15;63(6):730-734. doi: 10.1093/cid/ciw364. Epub 2016 Jun 30.
3
Enzyme-linked immunosorbent assay (ELISA) for antibodies to Clostridium difficile toxins in patients with pseudomembranous colitis and antibiotic-associated diarrhoea.
J Immunol Methods. 1983 Jun 10;60(3):341-50. doi: 10.1016/0022-1759(83)90291-0.
4
Immunoglobulin G directed against toxins A and B of Clostridium difficile in the general population and patients with antibiotic-associated diarrhea.
Diagn Microbiol Infect Dis. 1994 Apr;18(4):205-9. doi: 10.1016/0732-8893(94)90021-3.
5
Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI).
Vaccine. 2010 Jan 22;28(4):965-9. doi: 10.1016/j.vaccine.2009.10.144. Epub 2009 Nov 24.
6
Antigenicity of amino-acid sequences from Clostridium difficile toxin B.
J Med Microbiol. 1996 Jun;44(6):464-74. doi: 10.1099/00222615-44-6-464.
7
Serum antibody response to toxins A and B of Clostridium difficile.
J Infect Dis. 1983 Jul;148(1):93-100. doi: 10.1093/infdis/148.1.93.
8
Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin.
J Pediatr. 1991 Apr;118(4 Pt 1):633-7. doi: 10.1016/s0022-3476(05)83393-1.
9
Role of antibody response in outcome of antibiotic-associated diarrhoea.
Lancet. 2001 Jan 20;357(9251):158-9. doi: 10.1016/S0140-6736(00)03582-0.
10
Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease.
Inflamm Bowel Dis. 2013 Dec;19(13):2744-52. doi: 10.1097/01.MIB.0000435434.53871.36.
引用本文的文献
1
Clostridium difficile infection: molecular pathogenesis and novel therapeutics.
Expert Rev Anti Infect Ther. 2014 Jan;12(1):131-50. doi: 10.1586/14787210.2014.866515.
本文引用的文献
1
Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.
N Engl J Med. 2000 Feb 10;342(6):390-7. doi: 10.1056/NEJM200002103420604.
2
Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers.
J Immunol. 2000 Feb 15;164(4):1952-60. doi: 10.4049/jimmunol.164.4.1952.
3
Detection and transcription of toxin DNA in a nontoxigenic strain of Clostridium difficile.
Curr Microbiol. 1999 Jun;38(6):324-8. doi: 10.1007/pl00006811.
4
Clostridium difficile infection: appendix.
J Antimicrob Chemother. 1998 May;41 Suppl C:71-2. doi: 10.1093/jac/41.suppl_3.71.
5
6
Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection.
Infect Immun. 1994 Feb;62(2):384-9. doi: 10.1128/iai.62.2.384-389.1994.
7
Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal disease.
Infect Immun. 1995 Aug;63(8):3166-73. doi: 10.1128/iai.63.8.3166-3173.1995.
8
Concomitance of cytotoxigenic and non-cytotoxigenic Clostridium difficile in stool specimens.
J Clin Microbiol. 1983 Oct;18(4):1006-7. doi: 10.1128/jcm.18.4.1006-1007.1983.
9
Serum antibody response to Clostridium difficile toxins in patients with Clostridium difficile diarrhoea.
Infection. 1985 May-Jun;13(3):97-101. doi: 10.1007/BF01642866.
10
Systemic and mucosal antibody responses to toxin A in patients infected with Clostridium difficile.
J Infect Dis. 1992 Dec;166(6):1287-94. doi: 10.1093/infdis/166.6.1287.
Zotero 插件